SFPO and ESOP recommendations for the practical stability of anticancer drugs: an update.

Vigneron J,Astier A,Trittler R, Hecq J D,Daouphars M, Larsson I, Pourroy B, Pinguet F, Null Null

Annales Pharmaceutiques Françaises（2013）

引用 24|浏览3

暂无评分

摘要

The recommandations for the practical stability of anticancer drugs published in 2010 by the French Society of Hospital Pharmacists (SFPO) and the European Society of Oncology Pharmacists (ESOP) have been updated. Ten new molecules have been included (asparaginase, azacitidine, bevacizumab, clofarabine, eribuline mesylate, folinate sodium, levofolinate calcium, nelarabine, rituximab, temsirolimus).

查看译文

关键词

Stability,Anticancer drugs,Monoclonal antibodies,Dose banding,Stabilis®

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要